Cancer and the workplace

Breast conservation therapy

Personalised medicine for rare cancers

Working With Cancer: helping people affected by cancer return to work

Bendamustine for indolent lymphoma reduces relapse after 10 years

ShortHER trastuzumab treatment of HER2 breast cancer: 9 weeks v 1 year

T-VEC and checkpoint therapy for melanoma

Dacomitinib for EGFR positive lung cancer

Treating advanced melanoma with ipilimumab and HF10

Treating BRCA breast cancer with PARP inhibition

Relieving spinal cord compression symptoms with a single radiation treatment

Halving duration of ADT for high risk prostate cancer patients